Literature DB >> 1734300

MR-based hippocampal volumetry in the diagnosis of Alzheimer's disease.

C R Jack1, R C Petersen, P C O'Brien, E G Tangalos.   

Abstract

We evaluated a new magnetic resonance (MR)-based technique for performing volumetric measurements of temporal lobe structures. The technique was designed to assist in making the clinical diagnosis of dementia of the Alzheimer type (DAT). We chose specific anatomic regions of interest because of their known involvement in memory function and in the neuropathology of DAT and used a regression model to assess the effects of age on the volumes of the anterior temporal lobe (ATL) and the hippocampal formation (HF). These measurements were normalized by total intracranial volume (TIV). The volumetric measurements of both the normalized ATL and HF were significantly smaller (p less than 0.001) in DAT patients (N = 20) than in controls (N = 22), but the HF volumes provided much better separation between the two groups. Eighty-five percent of the DAT patients fell below the range of the HF/TIV measurement for the control subjects. This separation held up over the entire age range studied. Normalized volumes of both the HF and ATL decreased with age significantly for both the DAT patients and the controls. These results support the contention that MR-based HF volumetric measurements are accurate in differentiating DAT patients from cognitively normal elderly individuals. This technique may be a useful adjunct in making the clinical diagnosis of DAT.

Entities:  

Mesh:

Year:  1992        PMID: 1734300     DOI: 10.1212/wnl.42.1.183

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  230 in total

1.  Magnetic resonance imaging of the post-mortem autistic brain.

Authors:  C M Schumann; M H Buonocore; D G Amaral
Journal:  J Autism Dev Disord       Date:  2001-12

2.  Magnetization transfer measurements of the hippocampus in patients with Alzheimer's disease, vascular dementia, and other types of dementia.

Authors:  H Hanyu; T Asano; T Iwamoto; M Takasaki; H Shindo; K Abe
Journal:  AJNR Am J Neuroradiol       Date:  2000-08       Impact factor: 3.825

3.  Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment.

Authors:  C R Jack; R C Petersen; Y C Xu; P C O'Brien; G E Smith; R J Ivnik; B F Boeve; S C Waring; E G Tangalos; E Kokmen
Journal:  Neurology       Date:  1999-04-22       Impact factor: 9.910

Review 4.  Alliance for aging research AD biomarkers work group: structural MRI.

Authors:  Clifford R Jack
Journal:  Neurobiol Aging       Date:  2011-12       Impact factor: 4.673

5.  Gray matter network associated with risk for Alzheimer's disease in young to middle-aged adults.

Authors:  Gene E Alexander; Kaitlin L Bergfield; Kewei Chen; Eric M Reiman; Krista D Hanson; Lan Lin; Daniel Bandy; Richard J Caselli; James R Moeller
Journal:  Neurobiol Aging       Date:  2012-03-08       Impact factor: 4.673

6.  MRI as a biomarker of disease progression in a therapeutic trial of milameline for AD.

Authors:  C R Jack; M Slomkowski; S Gracon; T M Hoover; J P Felmlee; K Stewart; Y Xu; M Shiung; P C O'Brien; R Cha; D Knopman; R C Petersen
Journal:  Neurology       Date:  2003-01-28       Impact factor: 9.910

7.  In vivo analysis of hippocampal subfield atrophy in mild cognitive impairment via semi-automatic segmentation of T2-weighted MRI.

Authors:  John Pluta; Paul Yushkevich; Sandhitsu Das; David Wolk
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

8.  Longitudinal MRI atrophy biomarkers: relationship to conversion in the ADNI cohort.

Authors:  Shannon L Risacher; Li Shen; John D West; Sungeun Kim; Brenna C McDonald; Laurel A Beckett; Danielle J Harvey; Clifford R Jack; Michael W Weiner; Andrew J Saykin
Journal:  Neurobiol Aging       Date:  2010-08       Impact factor: 4.673

Review 9.  Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD.

Authors:  Lisa Mosconi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-04       Impact factor: 9.236

10.  An APOE-independent cis-eSNP on chromosome 19q13.32 influences tau levels and late-onset Alzheimer's disease risk.

Authors:  Shuquan Rao; Mahdi Ghani; Zhiyun Guo; Yuetiva Deming; Kesheng Wang; Rebecca Sims; Canquan Mao; Yao Yao; Carlos Cruchaga; Dietrich A Stephan; Ekaterina Rogaeva
Journal:  Neurobiol Aging       Date:  2018-01-03       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.